4//SEC Filing
Lion Biotechnologies, Inc. 4
Accession 0001250853-14-000024
$IOVACIK 0001425205operating
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 2:29 PM ET
Size
5.4 KB
Accession
0001250853-14-000024
Insider Transaction Report
Form 4
Singh Manish
DirectorPresident & CEO10% Owner
Transactions
- Award
Common Stock
2013-12-30+607,500→ 2,546,000 total
Footnotes (1)
- [F1]These shares were issued to the reporting person pursuant to a merger agreement between Lion Biotechnologies, Inc. and Genesis Biopharma, Inc. dated July 24, 2013 whereby upon the completion of the closing price per share of the Issuer's common stock equaling or exceeding $4.00 per share (as adjusted for the recent reverse stock split), and $100,000 of the Issuer's common stock trading for ten (10) days out of thirty (30) consecutive trading days within 12 months following the merger, additional shares would be issued to the reporting person. The Issuer's common stock achieved these milestones and the Board approved the issuance of these shares on December 30, 2013.
Documents
Issuer
Lion Biotechnologies, Inc.
CIK 0001425205
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001425205
Filing Metadata
- Form type
- 4
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 2:29 PM ET
- Size
- 5.4 KB